Introduction {#s1}
============

HBV infection remains a severe public health problem worldwide [@pone.0056444-Liu1], [@pone.0056444-Torpy1]. Each year around the world, HBV infection is responsible for about one million deaths due to liver failure, cirrhosis and more than 75% of the hepatocellular carcinomas world-wide develop from HBV infection [@pone.0056444-Ganem1], [@pone.0056444-Goldstein1].

Prior to 2006, China had been classified as an area with high prevalence of HBV [@pone.0056444-Andre1]. According to a national study published in the early 1979, the overall prevalence of chronic HBV carriage was approximately 8.75% [@pone.0056444-Chen1], which rose to 9.75% in 1992 [@pone.0056444-Xia1]. Following recommendations from the WHO, the Expanded Program on Immunization (EPI) for infants was established in China in 1992, and caused a significant decline in HBV prevalence to 7.18% according to a national survey in 2006 [@pone.0056444-Liang1]. Moreover, significant variations in the seroepidemiology of HBV across regions in China were found, with the highest rate observed in the mid-south, and lowest rate in northern China. The prevalence of HBsAg in Zhejiang Province, which is located in the south of China, was found to be over 11% in 1992, higher than the national rate, but had declined to 5.8% by 2001 [@pone.0056444-Yao1].

In the insular regions of Zhejiang Province, due in part to a more developed economy, and a high floating population, the prevalence of HBsAg in the residents was found to be 19.33% in 1997, notably higher than that in Zhejiang Province as a whole [@pone.0056444-Yu1]. Although the EPI, which started from 1992 in these islands, was considered a success in this region, an epidemiological study of 3657 randomly selected fishermen in the coastal islands of Zhejiang Province found that the prevalence of anti-HBc, a marker of HBV exposure was 61.4%, and the prevalence of HBsAg, a marker of active infection, was 15.5% in 2007 [@pone.0056444-Tang1]. This prevalence rate, although slightly lower than in the past, is still much higher than that for the entire Zhejiang Province (6.75%) [@pone.0056444-Li1].

However, to date, there have been very few HBV seroepidemiological studies on isolated islands. The community positivity rate of HBsAg in this region, and related risk factors remain unknown. The purpose of this project was to conduct a community-based epidemiological study to determine the prevalence of HBV infection in two major islands of southeast China, and to provide the most recent baseline data for planning and monitoring of health.

Methods {#s2}
=======

Study Population and Sampling Strategy {#s2a}
--------------------------------------

With the support of the Mega-Project for National Science and Technology Development for the "11th Five-Year Plan of China", and the Department of Health of Zhejiang Province, we conducted an investigation on two major islands of Zhejiang Province from October 2010 to March 2012. Two coastal municipalities were randomly chosen. From each municipality, we selected one insular-county/city (equivalent to a county). Zhoushan and Yuhuan are two isolated islands which are connected to the mainland by a bridge. Most of the people make a living by fishing. The towns/subdistricts in each region were divided into three levels according to economic development. In each level, one town/subdistrict was randomly selected. Finally, within each town/subdistrict, three villages/communities were also selected according to the economic level. A list of residents from the resident's committee was obtained using a registration book.

After receiving appropriate training by the lead researchers for this study, the physicians of each participating hospital began to conduct medical examinations, interviews, and laboratory tests on subjects who volunteered for free medical and health examinations. Altogether, approximately 360 physicians from 18 hospitals in the two insular counties were invited by the Department of Health of Zhejiang Province to participate. All local residents and migrant workers who had lived on these islands for \>3 months (*i.e.*, moved to the area before July 1, 2010) were screened for inclusion. The final average participation rate was about 60% among all the participating sites. The information collected consisted of demographics (sex, age, occupation, nationality, and marital status), residency status, medical history (e.g., blood transfusion, hepatitis B, allergies), and laboratory tests (HBsAg, anti-HBs, anti-HBc, AFP, ALT assays, and liver ultrasound (US)). Patients who had been diagnosed with HCV, HDV, HIV, immunosuppression disorders, or were on antiviral therapy, had alcohol abuse, or other liver diseases were excluded from the study.

All participants provided informed written consent and the informed written consent from the next of kin on the behalf of the minors/children participants. The data were analyzed anonymously. The study was approved by the Ethics Committee of The First Affiliated Hospital at the School of Medicine of Zhejiang University.

Serological Testing {#s2b}
-------------------

A 5 mL venous blood sample was collected from each participant using strict hygiene and safety guidelines. The patient demographic information, including name, sex, age, and district, were recorded. Blood samples were kept in a low temperature container (controlled from 4--10°C) and delivered to Adicon Clinical Laboratories (Hangzhou, China) on the same day for sample processing and serological testing.

Commercially available enzyme immunoassay kits (Acon Biotech Co., Hangzhou, China) were used for HBsAg, HBsAb, anti-HBc measurements. Verification of elevated test results was carried out by retesting the samples using the same kits. Only samples that were positive on both tests were considered to be true positives. For the purpose of analysis, HBsAg positivity was considered indicative of current HBV infection. Anti-HBc was used as an indicator of previous exposure to HBV. Isolated HBsAb positivity was taken to indicate successful HBV vaccination. Individuals who tested negative for all HBV serological markers were considered to be non-immune and non-infected.

Alanine Aminotransferase Levels and Hepatocellular Carcinoma Screening {#s2c}
----------------------------------------------------------------------

ALT is the most commonly used enzyme in the evaluation of liver disease. Serum ALT quantitation was performed within 2 hr of arrival at the laboratories. Quantitation was achieved using a coupled enzyme and indicator reaction that utilizes pyruvate for a kinetic determination of NADH consumption measured by an Architect C8000 automated biochemical analyzer (Abbott Laboratories, Abbott Park, IL, USA). Abnormal ALT values were defined as greater than 38 IU/L, representing 2.25 SD above the mean for normal subjects. Verification of elevated test results was carried out by retesting the samples using the same kits. Only samples that were positive on both tests were considered to be true positives. HCC community-based preliminary screening was performed for HBsAg-positive subjects by detection of α-fetoprotein (AFP) and imaging of the liver by ultrasound (US). Qualitative α-fetoprotein (AFP) screening for HCC was performed on participants \>30 years old (yo) who were HBsAg-positive, using an AFP EIA Test Kit (BoSai, Zhengzhou, China). Liver US was conducted by the doctors from the radiology department of each community health center. A preliminary diagnosis of HCC was made based on the presence of a positive AFP and a focal mass consistent with a tumor detected by US.

Data Analysis {#s2d}
-------------

Data were managed and analyzed using SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). For categorical variables, we used the chi-square test to determine group differences. A *P*\<0.01 was considered to be statistically significant. The HBsAg, anti-HBs and anti-HBc carrier rates were standardized by age and sex according to the 2010 Zhejiang population data [@pone.0056444-Statistics1] ^.^ The 95% confidence intervals (CI) for the proportion of individuals who were HBsAg-positive, stratified by age and sex, as well as for the whole group, were calculated.

Results {#s3}
=======

Characteristics of the Study Group {#s3a}
----------------------------------

A total of 15878 serum samples were tested. Information on age or sex was missing for 881 participants (5.5%). Thus, a total of 14997 samples were analyzed. To allow comparisons without distortion by age and sex, the prevalence was directly standardized to the age and sex distribution of all participants in the study population. In this study, the age groups and proportion of each were: \<20 yo (29.34%), 20--29 yo (14.46%), 30--39 yo (20.08%), 40--49 yo (13.94%), 50--59 yo (10.38%), 60--69 yo (6.83%), and ≥70 yo (4.97%) with the same sex proportion [@pone.0056444-Statistics1]. Demographic characteristics of the study population are shown in [Table 1](#pone-0056444-t001){ref-type="table"}.

10.1371/journal.pone.0056444.t001

###### Demographic data of the study population.

![](pone.0056444.t001){#pone-0056444-t001-1}

                        Participants   Number   Male      Mean
  ---------- --------- -------------- -------- ------- -----------
  Zhoushan    1121300       8932        8346    33.80   55.6±13.6
  Yuhuan      411000        6946        6651    44.60   41.1±21.4
  Total       1532300      15878       14997    38.60   49.2±18.9

Prevalence of HBV by Age and Sex {#s3b}
--------------------------------

A total of 1763 individuals tested positive for HBsAg ([Table 2](#pone-0056444-t002){ref-type="table"}). The prevalence of HBsAg positivity, a marker of current infection, in this population was 10.4% (95% CI: 9.9--10.9). The infection rate increased gradually from 1.7% in those \<20 yo to 17.0% in those 40--49 yo, reaching a peak in this decade of life, and declining thereafter ([Table 2](#pone-0056444-t002){ref-type="table"}). The prevalence among male participants (12.0%; 95% CI: 11.2--12.8) was significantly higher (*P*\<0.01) compared with that among female participants (8.8%; 95% CI: 8.3--9.3) ([Figure 1](#pone-0056444-g001){ref-type="fig"}).The prevalence of anti-HBc, a marker of HBV exposure, was 33.1% (95% CI: 32.4--33.8) overall, but did not vary significantly between the genders. The study showed that exposure increased with age both in males and in females, and reached a peak in the 40--49 yo group, declining thereafter, indicating exposure to HBV had occurred in all age groups ([Figure 2](#pone-0056444-g002){ref-type="fig"}).The prevalence of anti-HBs increased from 50.9% to 57.7% in the 20--69 yo group, and more than 60% among those ≥70 yo. Isolated anti-HBs, evidence of HBV vaccine-induced immunity, was found in approximately 39.3% (95% CI: 38.5--40.1) ([Table 2](#pone-0056444-t002){ref-type="table"}).

![Age-specific prevalence of hepatitis B virus surface antigen (HBsAg).](pone.0056444.g001){#pone-0056444-g001}

![Age-specific prevalence of anti-HBV core antibody (anti-HBc).](pone.0056444.g002){#pone-0056444-g002}

10.1371/journal.pone.0056444.t002

###### Prevalence of hepatitis B virus markers, stratified by age group.

![](pone.0056444.t002){#pone-0056444-t002-2}

            Only anti-HBs   HBsAg    anti-HBc    anti-HBs                                   
  -------- --------------- ------- ------------ ---------- ------------ ------ ------------ ------
  \<20        943/1725      54.7     30/1725       1.7       132/1725    7.7    1019/1725    59.1
  20--29       144/550      26.2      64/550       11.6      225/550     40.9    280/550     50.9
  30--39      450/1439      31.3     206/1439      14.3      630/1439    43.8    777/1439    54.0
  40--49      1038/3083     33.7     525/3083      17.0     1420/3083    46.1   1676/3083    54.4
  50--59      1324/3637     36.4     487/3637      13.4     1596/3637    43.9   2099/3637    57.7
  60--69      947/2648      35.8     307/2648      11.6     1194/2648    45.1   1504/2648    56.8
  ≥70         774/1915      40.4     144/1915      7.5       775/1915    40.5   1191/1915    62.2
  Total      5620/14997     39.3    1763/14997     10.4     5972/14997   33.1   8546/14997   56.1

The proportion of individuals who were positive were standardized by age.

Prevalence of HBV Stratified by Participant Islands {#s3c}
---------------------------------------------------

In [Table 3](#pone-0056444-t003){ref-type="table"}, HBV prevalence was calculated according to participant gender in each district. The total prevalence was calculated by adjusting for the population of each island in addition to sex ratio. The prevalence of HBsAg was significantly higher (*P*\<0.01) in the Zhoushan group (14.8%; 95% CI: 14.0--15.6) than in the Yuhuan group (9.1%; 95% CI: 8.4--9.8). On each island, the prevalence of HBsAg was higher in males than in females. The prevalence among male individuals in Zhoushan was 17.1% (95% CI: 15.7--18.5).The prevalence of anti-HBc was 43.3% and 35.7% in the Zhoushan and Yuhuan groups, respectively. The prevalence of anti-HBc in the Zhoushan group was significantly higher than in the Yuhuan group (*P*\<0.01), whereas there was no significant difference between males and females on either island. The prevalence of anti-HBs showed a trend similar to the prevalence of HBsAg in the two island groups, with prevalences of 59.1% and 54.8% in the Zhoushan and Yuhuan groups, respectively. The prevalence of vaccination-induced immunity (isolated anti-HBs) was also higher (*P*\<0.01) in the Zhoushan group ([Table 3](#pone-0056444-t003){ref-type="table"}).

10.1371/journal.pone.0056444.t003

###### Prevalence of HBV markers, stratified by region.

![](pone.0056444.t003){#pone-0056444-t003-3}

                       Only anti-HBs   HBsAg   anti-HBc    anti-HBs                                 
  ---------- -------- --------------- ------- ----------- ---------- ----------- ------ ----------- ------
  Zhoushan     Male      1149/2818     40.8    481/2818      17.1     1228/2818   43.6   1675/2818   59.4
              Female     2066/5528     37.4    697/5528      12.4     2371/5528   42.9   3224/5528   58.3
              Total      3215/8346     39.1    1178/8346     14.8     3599/8346   43.3   4899/8346   59.1
  Yuhuan       Male      1110/2966     37.4    300/2966      10.1     1043/2966   35.2   1617/2966   54.5
              Female     2405/3685     35.1    295/3685      8.0      1330/3685   36.1   2030/3685   55.1
              Total      55.1/6651     36.3    595/6651      9.1      2373/6651   35.7   3647/6651   54.8

The proportion of individuals who were positive were standardized by gender.

Hepatocellular Carcinoma Screening in the HBsAg Positive Group and ALT Levels {#s3d}
-----------------------------------------------------------------------------

There were ten HBsAg-positive patients, three female and seven male, \>30 yo (0.6%) who were AFP positive. However, no tumors were found by liver US. The mean (±SD) ALT was 21.1 (±19.0), and the proportion of participants with elevated ALT (≥38 IU/L) was 8.2%. The HBsAg-positive group had a significantly higher level of ALT (27.7 IU/L) compared with the HBsAg-negative group (21.0 IU/L). The proportion of patients with elevated ALT was significantly higher in the HBsAg-positive group (15.6%) compared with the HBsAg-negative group (7.2%)(P\<0.01). In both HBsAg-positive and HBsAg-negative groups, the proportion with elevated ALT was significantly higher in male than in female participants (*P*\<0.01) ([Table 4](#pone-0056444-t004){ref-type="table"}). In all participants, the proportion of elevated ALT was markedly higher in males (12.0%) than in females (5.8%)(P\<0.01). The male participant average ALT level (23.2 IU/L) was higher than that of the female participants (18.3 IU/L). The proportion of patients with elevated ALT significantly decreased with age, from 10.7% in the 40--49 yo group to 5.5% in the 70 yo group (*P*\<0.01) ([Figure 3](#pone-0056444-g003){ref-type="fig"}).

![Age-specific proportion of elevated alanine aminotransferase.](pone.0056444.g003){#pone-0056444-g003}

10.1371/journal.pone.0056444.t004

###### Number and proportion of elevated ALT in HBsAg positive and HBsAg negative groups.

![](pone.0056444.t004){#pone-0056444-t004-4}

            HBsAg-positive   HBsAg-negative                                                                                       
  -------- ---------------- ---------------- ------ ---------- -------- ------ ------------- -------- ------ ----------- -------- ------
  Serum                          ALT±SD                         ALT±SD                        ALT±SD                      ALT±SD  
  ALT          no. test          (IU/L)        \%    no. test   (IU/L)    \%     no. test     (IU/L)    \%    no. test    (IU/L)    \%
  Male         588/761            26.8        77.3   173/761     74.5    22.7    4500/5023     17.2    89.6   523/5023     60.4    10.4
                                 ±27.3                          ±74.6                          ±7.4                       ±30.2   
  Female       892/992            18.4        89.9   100/992     77.8    10.1    7791/8221     15.5    4.89   430/8221     55.4    5.2
                                  ±7.1                          ±79.0                          ±6.7                       ±24.4   
  Total       1480/1753           22.0        84.4   273/1753    75.7    15.6   12291/13244    16.1    92.8   953/13244    58.2    7.2
                                 ±19.0                          ±76.1                          ±7.0                       ±27.8   

Discussion {#s4}
==========

In Zhejiang Province, the EPI vaccination program is considered a success. Since program initiation in 1992, the high risk hepatitis B designation has moved from infants and children (0--9 yo) and adults (30--39 yo) to middle aged adults (40--49 yo) [@pone.0056444-Luo1]. In the current study, the infection rate of insular residents 40--49 yo was the highest, which is consistent with the findings of a previous epidemiological study. It appears that government programs should continue to target island persons, particularly those in the 40--49 yo group, for HBV-related education, and screening to reduce HBV spread among a wider population.

The national HBsAg prevalence in individuals aged 1--59 yo has been reported to be 7.18% in 2006, which represents a 26.3% decrease from 9.75% in 1992. The rate of HBsAg positivity in insular regions of southeast China fell from 19.93% in 1997 to 15.5% in 2007, a reduction of 22.2%, which is similar to the trend in the rest of China. This may be related to the efficient implementation of the vaccination policy in China. Data obtained from the national survey in 2005 revealed that the HBV vaccination series completion rate of infants was approximately 90.7% in rural areas, and 95.0% in urban areas [@pone.0056444-Cui1]. The completion rate in Zhejiang province reached 93.03% by 1997, and the coverage rate has increased over the years [@pone.0056444-Yao2].

The rate of HBsAg positivity varies considerably in different regions of China. For example, the rate of HBsAg positivity in Guangdong Province is 12.45% [@pone.0056444-Wang1], but only 3.49% in Beijing [@pone.0056444-Wu1]. Our study demonstrated that HBV infection is still highly endemic in insular regions where 33.1% of people have been exposed to HBV, with about 10.4% having markers consistent with chronic HBV infection. Although the prevalence in insular regions has declined compared with that in 2007, when the exposure rate was 61.4% and the HBsAg positivity was 15.5% [@pone.0056444-Tang1], it still much higher than the latest result of 6.13% in Zhejiang Province as a whole [@pone.0056444-Yang1]. Zhejiang Province is an affluent coastal province. Because of the port economy, the insular regions have a more developed economy. However, the high floating population and the special lifestyle on the islands may negatively influence the prevalence of HBsAg. At present, the vaccination program is only for newborns on these islands. According to the current study, the government should consider investing more funds for vaccination of individuals in the insular regions, especially for the high risk group\>20 yo who lack protective antibodies, and who were not vaccinated since 1992. Also, the government should pay more attention to the floating population compared with the other districts of China.

The prevalence rate of anti-HBc on the islands increased significantly with age, as other studies have observed[@pone.0056444-Nguyen1]--[@pone.0056444-Wang2]. This indicates that horizontal transmission still plays an important role in China. In 20--29 yo individuals, up to 40% of people living on the islands have already been exposed to the HBV, confirming that HBV infection occurs at a high rate in early life.

The prevalence of HBsAg positivity was found to be significantly associated with gender (males: 21.9% vs. females: 14.7%; *P*\<0.01) in the current study, which is consistent with previous observations[@pone.0056444-Wang2]--[@pone.0056444-Pereira1]. This finding may reflect pathogenesis-related mechanisms involving sex hormones. However, it is also possible that the findings are related to differences in lifestyle or behavior between males and females, such as smoking, drinking, extensive social range, physical activity, dining out, hygiene, and sexual activity. Particularly in insular regions, the activity of fishing is male dominated. The fishermen spend a lot of time eating and living together at sea each year. They do not pay attention to hygiene and there are different lifestyles and diets compared to non-fishermen. Therefore, health education urgently needs to be adjusted to the fisherman\'s lifestyle.

The study also compared the difference between the Zhoushan and Yuhuan groups, and showed that the positivity rate of HBsAg and anti-HBc in the Zhoushan group was higher than those of the Yuhuan group. Zhoushan is located in the north part of Zhejiang Province with a more developed economy and prosperous ports than Yuhuan. Moreover, the large floating population in Zhoushan increases the difficulty of health education and management [@pone.0056444-Chen2]. This indicates that in different insular regions, at least in part because of the differences in economic development and the floating population, the prevalence of hepatitis B is clearly different. Both these two areas were included in the EPI in 1992, whereas Zhoushan initiated immunization of children in the floating population in 1999 [@pone.0056444-Fu1]. Yuhuan instituted immunization of children in 1992. This may explain the observed difference in anti-HBs prevalence between the two islands in the current study.

ALT levels were found to be significantly related to HBsAg status on the islands. The HBsAg-positive group had a higher level of elevated ALT compared with the HBsAg-negative group (15.6% vs. 7.2%; p\<0.01). Abnormal ALT levels were significantly more frequent among HBsAg carriers than among those who were not.

The association between ALT and age or gender was also found in the current study, which agrees with previous studies which reported that males were associated with higher levels of ALT than females. However, unlike previous studies, we found that individuals ≥50 years did not have higher levels of ALT [@pone.0056444-Hayashi1], [@pone.0056444-Chu1].

A population-based cohort study from Japan found that even virus-negative participants with an ALT level exceeding 30 IU/L had a statistically higher risk of HCC than virus-positive patients with an ALT level under 30 IU/L [@pone.0056444-Ishiguro1]. The latter comprised a large proportion of participants in the current study. However, most of them were asymptomatic. Therefore, it is important for patients to participate in periodic examinations by the government.

This is the first study in China to screen for hepatic tumors in isolated islands on the basis of AFP and liver US in the general community. Although no cases of HCC were identified, we found the prevalence of abnormal AFP among HBsAg-positive individuals aged \>30 yo was 0.6%, far above the recently reported 0.2% found in Zhejiang Province as a whole [@pone.0056444-Luo1]. Hepatocellular carcinoma is the fifth leading malignancy and the third most deadly disease worldwide. In China, 110,000 people die of liver cancer annually, and account for 45% of the deaths globally. Thereinto, 70--80% of the liver cancer is related to hepatitis B [@pone.0056444-Shi1], [@pone.0056444-Nguyen2].

This study has several limitations that should be considered. First, some acute patients with hepatitis B were included in the hepatitis B carriers selected for the study. In a cross-sectional study, it is difficult to identify an acute infection due to lack of follow up, so the real prevalence of chronic hepatitis B in insular regions may be lower than that reported. Second, HBV virological assessment including HBV DNA levels and HBV genotypes were not performed. We did not analyze the clinical features of hepatitis, including jaundice, fatigue, and hepatic failure, in our community-based population, which may be significant among individuals.

In conclusion, this community-based study of insular regions provides information that might be useful in the design and implementation of future prevention strategies. Due to the geographic location, we found that HBV prevalence and potential risk of development of hepatocellular carcinoma remained high in insular regions of southeast China, and far above the national rates. Although the vaccination program has been implemented over the past 20 years, hepatitis B infection remains a great challenge for disease control in China. According to our research results, the government needs to undertake more long-term measures, such as the management of the high risk people, the floating population living on the islands, expansion of the immune population, and improved health education for fishermen.
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